Biomotiv LLC, of Cleveland, appointed Satish Jindal CEO.
Complexa Inc., of Berwyn, Pa., appointed Elisabeth Leiderman chief business officer.
DBV Technologies SA, of Montrouge, France, appointed Pascal Wotling chief technical operations officer, effective April 1, 2020.
Frequency Therapeutics Inc., of Woburn, Mass., appointed Wendy Arnold chief people officer, and Lisa Geller head of intellectual property.
Immunomolecular Therapeutics LLC, of Aurora, Colo., appointed Stephen Dilly to its board.
Nymox Pharmaceutical Corp., of Hasbrouck Heights, N.J., appointed Russell I. Thomson vice president of quality and regulatory affairs.
Plus Therapeutics Inc., of Austin, Texas, appointed Andrew J. Sims chief financial officer. It also appointed Greg B. Petersen to its board and audit and compensation committees.
Trillium Therapeutics Inc., of Cambridge, Mass., appointed Paul Walker to its board. It also appointed Ali Behbahani board observer.
Vectivbio AG, of Basel, Switzerland, appointed Kevin Harris chief commercial officer.